Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Triterpene saponin found in species of Panax.
Cysteine-ITC conjugate, antioxidant; HDAC inhib...
PDE5/6 inhibitor.
CDK7 inhibitor
Synthetic steroid hormone, contraceptive; PR ag...
Nucleoside (deoxyguanosine) analog; DNA chain t...
Macrocyclic lactone.
Organosulfide found in Allium; cholesterol synt...
Triterpenoid
MEK1/2 and Raf inhibitor.
EZH2 HMT inhibitor.
Reversible DNMT1-selective inhibitor
Endogenous peptide hormone, involved in intesti...
Macrolide; protein translation inhibitor, mamma...
Peptide, HIV-1 RT A2.1 epitope.
Quinazolinone; mitochondrial division inhibitor...
p110γ PI3K inhibitor.
Precursor in the synthesis of hydroquinone, ant...
Aminoglycoside; protein translation inhibitor, ...